What does european hospital liability — year 8 mean?

This metric quantifies the performance of the European hospital liability insurance segment in the eighth year of the reporting cycle. It provides insight into the revenue generation and risk profile of insurance products tailored for European hospital systems. This data is essential for evaluating the long-term viability and strategic importance of the company's European healthcare insurance operations.

King Pharmaceuticals KG European Hospital Liability — Year 8

Other product segments

General Liability

6.4%—

Commercial Auto Liability

2.3%—

All other lines

0.1%—

International

-0.1%—

Similar metrics at other companies

GLREHealth — Year 8

0%—

CNAMedical Professional Liability — Year 8

2.9%-0.3pp

AIGUK/Europe Casualty and Financial lines — Year 8 (as a percent)

5.7%+0.4pp

AIGUK/Europe and Japan Personal Insurance — Year 8 (as a percent)

0.3%-0.1pp

AXSInsurance — Year 8

6.8%—

CNAInternational — Year 8

2.6%—

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's european hospital liability — year 8.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's european hospital liability — year 8?: King Pharmaceuticals (KG) reported european hospital liability — year 8 of 5% in Q4 2025.
What does european hospital liability — year 8 mean?: This metric quantifies the performance of the European hospital liability insurance segment in the eighth year of the reporting cycle. It provides insight into the revenue generation and risk profile of insurance products tailored for European hospital systems. This data is essential for evaluating the long-term viability and strategic importance of the company's European healthcare insurance operations.